Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1994 1
2005 1
2009 3
2011 2
2012 3
2013 2
2014 2
2015 2
2016 2
2017 6
2018 4
2019 4
2020 5
2021 8
2022 4
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tingling, jiang
Search for tingting, jiang instead (1 results)
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Drilon A, Camidge DR, Lin JJ, Kim SW, Solomon BJ, Dziadziuszko R, Besse B, Goto K, de Langen AJ, Wolf J, Lee KH, Popat S, Springfeld C, Nagasaka M, Felip E, Yang N, Velcheti V, Lu S, Kao S, Dooms C, Krebs MG, Yao W, Beg MS, Hu X, Moro-Sibilot D, Cheema P, Stopatschinskaja S, Mehta M, Trone D, Graber A, Sims G, Yuan Y, Cho BC; TRIDENT-1 Investigators. Drilon A, et al. N Engl J Med. 2024 Jan 11;390(2):118-131. doi: 10.1056/NEJMoa2302299. N Engl J Med. 2024. PMID: 38197815 Clinical Trial.
A total of 426 patients received the phase 2 dose; the most common treatment-related adverse events were dizziness (in 58% of the patients), dysgeusia (in 50%), and paresthesia (in 30%), and 3% discontinued repotrectinib owing to treatment-related adverse events. ...
A total of 426 patients received the phase 2 dose; the most common treatment-related adverse events were dizziness (in 58% of the patients), …
Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Zhou R, Jiang F, Cai H, Zeng Q, Yang H. Zhou R, et al. Front Immunol. 2021 Apr 23;12:664364. doi: 10.3389/fimmu.2021.664364. eCollection 2021. Front Immunol. 2021. PMID: 33968065 Free PMC article. Review.
Therefore, case reports and literature review on N-Methyl-D-aspartate receptor antibody in patients with multiple sclerosis are unusual and noteworthy. A young female had the first episode of paresthesia and motor symptoms with positive anti-N-Methyl-D-Aspartate receptor a …
Therefore, case reports and literature review on N-Methyl-D-aspartate receptor antibody in patients with multiple sclerosis are unusual and …
Endovenous radiofrequency ablation vs laser ablation in patients with lower extremity varicose veins: A meta-analysis.
Jiang W, Liang Y, Long Z, Hu M, Yang H, Qin X. Jiang W, et al. J Vasc Surg Venous Lymphat Disord. 2024 Feb 3:101842. doi: 10.1016/j.jvsv.2024.101842. Online ahead of print. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38316290 Free article. Review.

RFA showed a reduced risk of burns and ecchymosis (OR, 0.65; 95% CI, 0.48-0.87; P = .005), postprocedural pain (mean difference, -0.85; 95% CI, -1.06 to -0.64; P < .001), recurrence of VVs (OR, 0.58; 95% CI, 0.36-0.92; P = .02), and paresthesia since 2016 (OR, 0.42; 95%

…
RFA showed a reduced risk of burns and ecchymosis (OR, 0.65; 95% CI, 0.48-0.87; P = .005), postprocedural pain (mean difference, -0.85; 95% …
Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements.
Raef HS, Rebeiz L, Leaf RK, Hughes O, Jiang P, ElSeht A, Anderson KE, Wheeden K, Kochevar I, Elmariah SB, Dickey AK. Raef HS, et al. JAMA Dermatol. 2023 Feb 1;159(2):204-208. doi: 10.1001/jamadermatol.2022.5850. JAMA Dermatol. 2023. PMID: 36630131 Free PMC article.
Phototoxic reactions were characterized by pain (97%; 34 patients), burning (97%; 34), tingling (97%; 34), pruritus (83%; 29), allodynia (89%; 31), improvement of symptoms with cold (89%; 31), achiness (24%; 12), fatigue (46%; 16), mild swelling (83%; 29), severe swelling …
Phototoxic reactions were characterized by pain (97%; 34 patients), burning (97%; 34), tingling (97%; 34), pruritus (83%; 29), allody …
The Long-Term Clinical Outcomes of Selectively Extracranial Radiofrequency Thermocoagulation for Trigeminal Neuralgia Guided by Three-Dimensionally Printed Personalized Template.
Jiang Z, Jiang S, Meng Q, Cai H, Ke J. Jiang Z, et al. J Craniofac Surg. 2022 Sep 1;33(6):1791-1794. doi: 10.1097/SCS.0000000000008443. Epub 2021 Dec 15. J Craniofac Surg. 2022. PMID: 36054891
Postoperative complications included facial numbness in 91 patients (77.8%), masticatory muscle weakness in 15 patients (12.8%), ear paresthesia in 3 patients (2.6%), limited mouth opening in 2 patients (1.7%), and taste hypesthesia in 2 patients (1.7%). ...
Postoperative complications included facial numbness in 91 patients (77.8%), masticatory muscle weakness in 15 patients (12.8%), ear pare …
Study on screening and evaluation methods of cosmetics for people with facial sensitive skin.
Lyu J, Diao QC, Wang S, Yu Y, Jiang Y. Lyu J, et al. Medicine (Baltimore). 2022 Aug 5;101(31):e29975. doi: 10.1097/MD.0000000000029975. Medicine (Baltimore). 2022. PMID: 35945772 Free PMC article.
First, the human skin enclosed patch test of cosmetic gel (abbreviated as gel) was performed, and then the tested products were continuously applied for 4 weeks to complete the long-term efficacy test. Subjects' sensation of application, pruritus, tingling and burning were …
First, the human skin enclosed patch test of cosmetic gel (abbreviated as gel) was performed, and then the tested products were continuously …
A Bayesian Network to Predict the Risk of Post Influenza Vaccination Guillain-Barré Syndrome: Development and Validation Study.
Huang Y, Luo C, Jiang Y, Du J, Tao C, Chen Y, Hao Y. Huang Y, et al. JMIR Public Health Surveill. 2022 Mar 25;8(3):e25658. doi: 10.2196/25658. JMIR Public Health Surveill. 2022. PMID: 35333192 Free PMC article.
The posttest probability of GBS suggested that male vaccinees aged 50-64 years and without erythema should be on the alert or be warned by clinicians about an increased risk of GBS, especially when they also experience symptoms of asthenia, hypesthesia, muscular weakness, or p …
The posttest probability of GBS suggested that male vaccinees aged 50-64 years and without erythema should be on the alert or be warned by c …
The prevalence and risk factors for physical impairments in Chinese post-cancer treated breast cancer survivors: a 4 years' cross-sectional study at a single center.
Chen D, Li L, Jiang LY, Jia J. Chen D, et al. Sci Rep. 2023 Oct 27;13(1):18458. doi: 10.1038/s41598-023-45731-x. Sci Rep. 2023. PMID: 37891422 Free PMC article.
The prevalence of lymphedema (65.9%) was higher than that of pain (31.2%), shoulder range of motion (ROM) restriction (20.3%), grip strength restriction (GSR) (21.7%) and paresthesia (11.6%). These impairments mainly appeared within 28 months after breast cancer diagnosis, …
The prevalence of lymphedema (65.9%) was higher than that of pain (31.2%), shoulder range of motion (ROM) restriction (20.3%), grip strength …
Key Characteristics of Nitrous Oxide-Induced Neurological Disorders and Differences Between Populations.
Zhang J, Xie D, Zou Y, Yu X, Ji Y, Wang C, Lv X, Zhou N, Jiang X, Wang K, Tian Y. Zhang J, et al. Front Neurol. 2021 Apr 27;12:627183. doi: 10.3389/fneur.2021.627183. eCollection 2021. Front Neurol. 2021. PMID: 33986715 Free PMC article.
Results: The most common initial symptoms of N(2)O-induced neurological disorders were weakness and/or paresthesia. Most patients presented with myelopathy and/or peripheral neuropathy. ...
Results: The most common initial symptoms of N(2)O-induced neurological disorders were weakness and/or paresthesia. Most patients pre …
53 results